Health-related quality of life (HRQoL) outcomes with darolutamide in the phase 3 ARANOTE trial. A multicenter, randomized, phase 2, investigator-initiated ETCTN trial of olaparib + radium-223 vs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback